PTI News and Press, Yumanity Therapeutics Inc Com

Brawijaya University develops GIS-based IoT for disaster mitigation Malang, East Java, Indonesia, Sept 30, 2022 - (ACN Newswire) - Brawijaya University has developed an Internet of Things (IoT) technology based on the Geographic Information System (GIS) to mitigate disasters i...

Proteostasis Therapeutics ([[PTI]]) and Yumanity Therapeutics have completed its reverse merger.The combined company will operate under the name Yumanity Therapeutics and its shares will commence trading on the Nasdaq Capital Market on December 23, 2020, under the ticker s...

Proteostasis Therapeutics, Inc. Stockholders Approve Business Combination with Yumanity Therapeutics, Inc.; Board Sets Reverse Stock Split Ratio PR Newswire BOSTON , Dec. 22, 2020 /PRNewswire/ -- Proteostasis Therapeutics, Inc. ("Proteostasis") (Nasdaq: PTI)...

Prevail Therapeutics (PRVL) +84% on being acquired by Lilly for ~$1.04B.OncoCyte Corporation (OCX) +63% after company enters agreement with Burning Rock Biotech.Anavex Life Sciences (AVXL) +40% as it's blarcamesine successful in mid-stage rett syndrome study.Mid-Con Energy Part...

Leading institutional investors commit $33.6 million through a common stock private investment in public equity (“PIPE”) led by Fidelity Management & Research Company, LLC and Invus Proteostasis plans to adjourn its special meeting of stockholders to December 2...

Atossa Therapeutics (ATOS) -42% on announcing pricing of $20M underwritten public offering.Pluristem Therapeutics (PSTI) -42% after DMC recommendation following interim analysis of its Phase III CLI study.Photronics PLAB -18% on Q4 earnings release.Talos Energy TALO -...

WeissLaw LLP Reminds CCR, TCO, UROV, and PTI Shareholders About Its Ongoing Investigations PR Newswire NEW YORK, Nov. 30, 2020 NEW YORK , Nov. 30, 2020 /PRNewswire/ -- If you own shares in any of the companies listed above and would like...

WeissLaw LLP Reminds PTI, MVC, and EIDX Shareholders About Its Ongoing Investigations PR Newswire NEW YORK, Nov. 23, 2020 NEW YORK , Nov. 23, 2020 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to d...

Proteostasis Therapeutics (PTI): Q3 GAAP EPS of -$0.16 beats by $0.02.Cash and short-term investments totaled $40.8M as of Sep. 30, 2020, compared to $69.5M as of Dec. 31, 2019.Research and development expenses stood at $1.2M vs. to $10.1M for the same period in the prior year.Press Release ...

Proteostasis Therapeutics Reports Third Quarter 2020 Financial Results PR Newswire BOSTON, Nov. 16, 2020 BOSTON , Nov. 16, 2020 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (Nasdaq:PTI), a clinical stage biopharmaceutical company, today announced fina...